Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial.

Porceddu SV, Bressel M, Poulsen MG, Stoneley A, Veness MJ, Kenny LM, Wratten C, Corry J, Cooper S, Fogarty GB, Collins M, Collins MK, Macann AMJ, Milross CG, Penniment MG, Liu HY, King MT, Panizza BJ, Rischin D.

J Clin Oncol. 2018 May 1;36(13):1275-1283. doi: 10.1200/JCO.2017.77.0941. Epub 2018 Mar 14.

PMID:
29537906
2.

Cost analysis of a speech pathology synchronous telepractice service for patients with head and neck cancer.

Burns CL, Kularatna S, Ward EC, Hill AJ, Byrnes J, Kenny LM.

Head Neck. 2017 Dec;39(12):2470-2480. doi: 10.1002/hed.24916. Epub 2017 Sep 30.

PMID:
28963804
3.

Erratum to: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.

Saleem A, Searle GE, Kenny LM, Huiban M, Kozlowski K, Waldman AD, Woodley L, Palmieri C, Lowdell C, Kaneko T, Murphy PS, Lau MR, Aboagye EO, Coombes RC.

EJNMMI Res. 2017 Sep 8;7(1):74. doi: 10.1186/s13550-017-0323-y. No abstract available.

4.

Impact of early prophylactic feeding on long term tube dependency outcomes in patients with head and neck cancer.

Brown T, Banks M, Hughes BGM, Lin C, Kenny LM, Bauer JD.

Oral Oncol. 2017 Sep;72:17-25. doi: 10.1016/j.oraloncology.2017.06.025. Epub 2017 Jul 5.

PMID:
28797454
5.

IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer.

Palmieri C, Szydlo R, Miller M, Barker L, Patel NH, Sasano H, Barwick T, Tam H, Hadjiminas D, Lee J, Shaaban A, Nicholas H, Coombes RC, Kenny LM.

Breast Cancer Res Treat. 2017 Nov;166(2):527-539. doi: 10.1007/s10549-017-4427-x. Epub 2017 Aug 9.

6.

Interventional radiology in breast cancer.

Kenny LM, Orsi F, Adam A.

Breast. 2017 Oct;35:98-103. doi: 10.1016/j.breast.2017.06.012. Epub 2017 Jul 10. Review.

PMID:
28704698
7.

Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer.

Brown TE, Banks MD, Hughes BGM, Lin CY, Kenny LM, Bauer JD.

Br J Cancer. 2017 Jun 27;117(1):15-24. doi: 10.1038/bjc.2017.138. Epub 2017 May 23.

8.

Baseline and longitudinal variability of normal tissue uptake values of [18F]-fluorothymidine-PET images.

Cysouw MCF, Kramer GM, Frings V, De Langen AJ, Wondergem MJ, Kenny LM, Aboagye EO, Kobe C, Wolf J, Hoekstra OS, Boellaard R.

Nucl Med Biol. 2017 Aug;51:18-24. doi: 10.1016/j.nucmedbio.2017.05.002. Epub 2017 May 10.

9.

Investigation of p16 status, chemotherapy regimen, and other nutrition markers for predicting gastrostomy in patients with head and neck cancer.

Brown TE, Wittholz K, Way M, Banks MD, Hughes BG, Lin CY, Kenny LM, Bauer JD.

Head Neck. 2017 May;39(5):868-875. doi: 10.1002/hed.24630. Epub 2017 Feb 23.

PMID:
28230929
10.

Randomized controlled trial of a multisite speech pathology telepractice service providing swallowing and communication intervention to patients with head and neck cancer: Evaluation of service outcomes.

Burns CL, Ward EC, Hill AJ, Kularatna S, Byrnes J, Kenny LM.

Head Neck. 2017 May;39(5):932-939. doi: 10.1002/hed.24706. Epub 2017 Feb 22.

PMID:
28225567
11.

Comparison of Nutritional and Clinical Outcomes in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy Utilizing Prophylactic versus Reactive Nutrition Support Approaches.

Brown TE, Banks MD, Hughes BGM, Lin CY, Kenny LM, Bauer JD.

J Acad Nutr Diet. 2018 Apr;118(4):627-636. doi: 10.1016/j.jand.2016.10.013. Epub 2016 Dec 13.

PMID:
27986517
12.

Image guided therapy and the importance of local tumour control.

Kenny LM, Adam A.

Eur J Surg Oncol. 2016 May;42(5):588-90. doi: 10.1016/j.ejso.2016.01.021. Epub 2016 Feb 17. No abstract available.

PMID:
26935446
13.

Validation of an updated evidence-based protocol for proactive gastrostomy tube insertion in patients with head and neck cancer.

Brown TE, Getliffe V, Banks MD, Hughes BG, Lin CY, Kenny LM, Bauer JD.

Eur J Clin Nutr. 2016 May;70(5):574-81. doi: 10.1038/ejcn.2015.230. Epub 2016 Feb 10.

PMID:
26862007
14.

New radiotherapy techniques do not reduce the need for nutrition intervention in patients with head and neck cancer.

Brown T, Banks M, Hughes BG, Lin C, Kenny LM, Bauer JD.

Eur J Clin Nutr. 2015 Oct;69(10):1119-24. doi: 10.1038/ejcn.2015.141. Epub 2015 Aug 26.

PMID:
26306565
15.

Improving guideline sensitivity and specificity for the identification of proactive gastrostomy placement in patients with head and neck cancer.

Brown TE, Crombie J, Spurgin AL, Tripcony L, Keller J, Hughes BG, Dickie G, Kenny LM, Hodge RA.

Head Neck. 2016 Apr;38 Suppl 1:E1163-71. doi: 10.1002/hed.24184. Epub 2015 Aug 13.

PMID:
26268152
16.

Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [(18)F]fluciclatide kinetics and [ (15)O]H 2O PET.

Kenny LM, Tomasi G, Turkheimer F, Larkin J, Gore M, Brock CS, Mangar S, Aboagye EO.

EJNMMI Res. 2014 Dec;4(1):30. doi: 10.1186/s13550-014-0030-x. Epub 2014 Aug 8.

17.

Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.

Saleem A, Searle GE, Kenny LM, Huiban M, Kozlowski K, Waldman AD, Woodley L, Palmieri C, Lowdell C, Kaneko T, Murphy PS, Lau MR, Aboagye EO, Coombes RC.

EJNMMI Res. 2015 Apr 30;5:30. doi: 10.1186/s13550-015-0103-5. eCollection 2015. Erratum in: EJNMMI Res. 2017 Sep 18;7(1):76. EJNMMI Res. 2017 Sep 8;7(1):74.

18.

Metabolically active tumour volume segmentation from dynamic [(18)F]FLT PET studies in non-small cell lung cancer.

Hoyng LL, Frings V, Hoekstra OS, Kenny LM, Aboagye EO, Boellaard R.

EJNMMI Res. 2015 Apr 23;5:26. doi: 10.1186/s13550-015-0102-6. eCollection 2015.

19.

Carcinoid-associated encephalopathy.

Femminella GD, Kenny LM, Sinha A, Amlani S, Edison P.

J Clin Gastroenterol. 2015 Apr;49(4):353-4. doi: 10.1097/MCG.0000000000000272. No abstract available.

20.

Interventional oncology in multidisciplinary cancer treatment in the 21(st) century.

Adam A, Kenny LM.

Nat Rev Clin Oncol. 2015 Feb;12(2):105-13. doi: 10.1038/nrclinonc.2014.211. Epub 2014 Dec 2. Review.

PMID:
25445561
21.

Clinical translation of molecular imaging agents used in PET studies of cancer.

Kenny LM, Aboagye EO.

Adv Cancer Res. 2014;124:329-74. doi: 10.1016/B978-0-12-411638-2.00010-0. Review.

PMID:
25287694
22.

18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.

Kenny LM.

J Nucl Med. 2013 Nov;54(11):1855-6. doi: 10.2967/jnumed.113.126342. Epub 2013 Sep 26. No abstract available.

23.

18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.

Challapalli A, Kenny LM, Hallett WA, Kozlowski K, Tomasi G, Gudi M, Al-Nahhas A, Coombes RC, Aboagye EO.

J Nucl Med. 2013 Sep;54(9):1551-6. doi: 10.2967/jnumed.112.118760. Epub 2013 Aug 15.

24.

Radiation oncology and interventional oncology: time for a collaborative approach.

Kenny LM, Adam A.

Clin Oncol (R Coll Radiol). 2013 Sep;25(9):515-8. doi: 10.1016/j.clon.2013.06.006. Epub 2013 Jul 3. No abstract available.

PMID:
23830705
25.

Quantification of intra-tumour cell proliferation heterogeneity using imaging descriptors of 18F fluorothymidine-positron emission tomography.

Willaime JM, Turkheimer FE, Kenny LM, Aboagye EO.

Phys Med Biol. 2013 Jan 21;58(2):187-203. doi: 10.1088/0031-9155/58/2/187. Epub 2012 Dec 21.

PMID:
23257054
26.

A pilot trial of a speech pathology telehealth service for head and neck cancer patients.

Burns CL, Ward EC, Hill AJ, Malcolm K, Bassett L, Kenny LM, Greenup P.

J Telemed Telecare. 2012 Dec;18(8):443-6. doi: 10.1258/jtt.2012.GTH104. Epub 2012 Dec 3.

PMID:
23209274
27.

The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment.

Monteiro LJ, Khongkow P, Kongsema M, Morris JR, Man C, Weekes D, Koo CY, Gomes AR, Pinto PH, Varghese V, Kenny LM, Charles Coombes R, Freire R, Medema RH, Lam EW.

Oncogene. 2013 Sep 26;32(39):4634-45. doi: 10.1038/onc.2012.491. Epub 2012 Oct 29.

28.

Validated swallowing and nutrition guidelines for patients with head and neck cancer: identification of high-risk patients for proactive gastrostomy.

Brown TE, Spurgin AL, Ross L, Tripcony L, Keller J, Hughes BG, Hodge R, Walker Q, Banks M, Kenny LM, Crombie J.

Head Neck. 2013 Oct;35(10):1385-91. doi: 10.1002/hed.23146. Epub 2012 Sep 13.

PMID:
22972623
29.

Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials.

Aboagye EO, Gilbert FJ, Fleming IN, Beer AJ, Cunningham VJ, Marsden PK, Visvikis D, Gee AD, Groves AM, Kenny LM, Cook GJ, Kinahan PE, Myers M, Clarke L; Experimental Cancer Medicine Centre 13 Imaging Network Group.

Eur Radiol. 2012 Jul;22(7):1465-78. doi: 10.1007/s00330-011-2311-3. Epub 2012 Apr 4.

PMID:
22476502
30.

Evaluation of limited blood sampling population input approaches for kinetic quantification of [18F]fluorothymidine PET data.

Contractor KB, Kenny LM, Coombes CR, Turkheimer FE, Aboagye EO, Rosso L.

EJNMMI Res. 2012 Mar 24;2:11. doi: 10.1186/2191-219X-2-11.

31.

Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.

Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S, Tomasi G, Al-Nahhas A, Mapelli P, Kenny LM, Tadrous P, Coombes RC, Aboagye EO, Mangar S.

Clin Cancer Res. 2011 Dec 15;17(24):7673-83. doi: 10.1158/1078-0432.CCR-11-2048. Epub 2011 Oct 28.

32.

[18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel.

Contractor KB, Kenny LM, Stebbing J, Rosso L, Ahmad R, Jacob J, Challapalli A, Turkheimer F, Al-Nahhas A, Sharma R, Coombes RC, Aboagye EO.

Clin Cancer Res. 2011 Dec 15;17(24):7664-72. doi: 10.1158/1078-0432.CCR-11-0783. Epub 2011 Oct 25.

33.

Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography.

Contractor KB, Kenny LM, Stebbing J, Challapalli A, Al-Nahhas A, Palmieri C, Shousha S, Lewis JS, Hogben K, De Nguyen Q, Coombes RC, Aboagye EO.

Nucl Med Commun. 2011 Nov;32(11):997-1004. doi: 10.1097/MNM.0b013e328349567b.

PMID:
21862943
34.

Review: lapatinib in metastatic colorectal cancer-another strategy for disease control?

Kenny LM, Lam EW.

Clin Adv Hematol Oncol. 2011 Jun;9(6):500-1. Review. No abstract available.

PMID:
21841752
35.

Novel PET biomarkers for breast cancer imaging.

Kenny LM, Al-Nahhas A, Aboagye EO.

Nucl Med Commun. 2011 May;32(5):333-5. doi: 10.1097/MNM.0b013e32834471ff. No abstract available.

PMID:
21304413
36.

Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements.

Hatt M, Cheze-Le Rest C, Aboagye EO, Kenny LM, Rosso L, Turkheimer FE, Albarghach NM, Metges JP, Pradier O, Visvikis D.

J Nucl Med. 2010 Sep;51(9):1368-76. doi: 10.2967/jnumed.110.078501. Epub 2010 Aug 18.

37.

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM, McArthur GA.

J Clin Oncol. 2010 Sep 20;28(27):4142-8. doi: 10.1200/JCO.2010.29.2904. Epub 2010 Aug 9.

38.

Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab.

Kenny LM, Contractor KB, Hinz R, Stebbing J, Palmieri C, Jiang J, Shousha S, Al-Nahhas A, Coombes RC, Aboagye EO.

Clin Cancer Res. 2010 Aug 15;16(16):4236-45. doi: 10.1158/1078-0432.CCR-10-0468. Epub 2010 Aug 3.

39.

Kinetic filtering of [(18)F]Fluorothymidine in positron emission tomography studies.

Gray KR, Contractor KB, Kenny LM, Al-Nahhas A, Shousha S, Stebbing J, Wasan HS, Coombes RC, Aboagye EO, Turkheimer FE, Rosso L.

Phys Med Biol. 2010 Feb 7;55(3):695-709. doi: 10.1088/0031-9155/55/3/010. Epub 2010 Jan 13.

PMID:
20071760
40.

Altered tissue 3'-deoxy-3'-[18F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography.

Kenny LM, Contractor KB, Stebbing J, Al-Nahhas A, Palmieri C, Shousha S, Coombes RC, Aboagye EO.

Clin Cancer Res. 2009 Nov 1;15(21):6649-57. doi: 10.1158/1078-0432.CCR-09-1213. Epub 2009 Oct 27.

41.

[11C]choline positron emission tomography in estrogen receptor-positive breast cancer.

Contractor KB, Kenny LM, Stebbing J, Al-Nahhas A, Palmieri C, Sinnett D, Lewis JS, Hogben K, Osman S, Shousha S, Lowdell C, Coombes RC, Aboagye EO.

Clin Cancer Res. 2009 Sep 1;15(17):5503-10. doi: 10.1158/1078-0432.CCR-09-0666. Epub 2009 Aug 25.

42.

Distant memories: a prospective study of vantage point of trauma memories.

Kenny LM, Bryant RA, Silove D, Creamer M, O'Donnell M, McFarlane AC.

Psychol Sci. 2009 Sep;20(9):1049-52. doi: 10.1111/j.1467-9280.2009.02393.x. Epub 2009 Jul 6.

PMID:
19594861
43.

The promiscuous receptor.

Newsom-Davis TE, Kenny LM, Ngan S, King J, Waxman J.

BJU Int. 2009 Nov;104(9):1204-7. doi: 10.1111/j.1464-410X.2009.08599.x. Epub 2009 Apr 24.

44.

The biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 18F-AH111585 in healthy volunteers.

McParland BJ, Miller MP, Spinks TJ, Kenny LM, Osman S, Khela MK, Aboagye E, Coombes RC, Hui AM, Cohen PS.

J Nucl Med. 2008 Oct;49(10):1664-7. doi: 10.2967/jnumed.108.052126. Epub 2008 Sep 15.

45.

Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients.

Kenny LM, Coombes RC, Oulie I, Contractor KB, Miller M, Spinks TJ, McParland B, Cohen PS, Hui AM, Palmieri C, Osman S, Glaser M, Turton D, Al-Nahhas A, Aboagye EO.

J Nucl Med. 2008 Jun;49(6):879-86. doi: 10.2967/jnumed.107.049452. Epub 2008 May 15.

46.

Clinical teleradiology--the purpose of principles.

Kenny LM, Lau LS.

Med J Aust. 2008 Feb 18;188(4):197-8. No abstract available.

PMID:
18279122
47.

Towards the appropriate use of diagnostic imaging.

Kenny LM, Goergen SK, Mandel CJ.

Med J Aust. 2007 Oct 15;187(8):473; author reply 474. No abstract available.

PMID:
17937648
48.

Addressing radiology workforce issues.

Kenny LM, Andrews MW.

Med J Aust. 2007 Jun 18;186(12):615-6. No abstract available.

PMID:
17576174
49.

'Time, gentlemen, please' for watchful waiting in prostate cancer?

Kenny LM, Ngan S, Waxman J.

BJU Int. 2007 Aug;100(2):244-6. Epub 2007 Jun 5. No abstract available.

50.

Keeping memories at an arm's length: vantage point of trauma memories.

Kenny LM, Bryant RA.

Behav Res Ther. 2007 Aug;45(8):1915-20. Epub 2006 Nov 13.

PMID:
17097605

Supplemental Content

Loading ...
Support Center